Filing Details
- Accession Number:
- 0001859061-23-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-04-06 18:43:47
- Reporting Period:
- 2023-03-31
- Accepted Time:
- 2023-04-06 18:43:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1840439 | Biomea Fusion Inc. | BMEA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1859061 | A2A Pharmaceuticals, Inc. | 59 5Th Ave New York NY 10003 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-03-31 | 200,000 | $31.25 | 4,100,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- A total of 200,000 shares were sold at an average price of 31.25 in multiple transactions ranging in price from 30.87 to 31.64
Billionaire Hedge Funds
